Adoptive Cell Therapies Using Unconventional T Lymphocytes

This publication has 114 references indexed in Scilit:

• Empowering γδ T‐cell functionality with vitamin C
  European Journal of Immunology, 2024
• Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid
  International Journal of Hematology, 2024
• Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia
  Cancer Immunology, Immunotherapy, 2023
• Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy
  Cancer Letters, 2023
• CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
  Cancer Immunology, Immunotherapy, 2022
• Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
  Clinical & Translational Immunology, 2022
• Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy
  Bulletin du Cancer, 2021
• Regulatory T cells induce CD4− NKT cell anergy and suppress NKT cell cytotoxic function
  Cancer Immunology, Immunotherapy, 2019
• Regulatory and effector functions of gamma–delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer
  International Journal of Cancer, 2016
• Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
  Cancer Immunology, Immunotherapy, 2011